Usana Health Sciences Analyst Ratings
Usana Health Sciences Analyst Ratings
While ratings are subjective and will change, the latest Usana Health Sciences (USNA) rating was a maintained with a price target of $62.00 to $53.00. The current price Usana Health Sciences (USNA) is trading at is $45.25, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/25/2023 | 17.13% | DA Davidson | $62 → $53 | Maintains | Neutral |
| 04/26/2023 | 23.76% | DA Davidson | $52.5 → $56 | Maintains | Neutral |
| 02/13/2023 | 16.02% | DA Davidson | $49 → $52.5 | Maintains | Neutral |
| 10/27/2022 | 8.29% | DA Davidson | $57 → $49 | Maintains | Neutral |
| 07/28/2022 | 25.97% | DA Davidson | $58 → $57 | Maintains | Neutral |
| 07/12/2022 | 28.18% | DA Davidson | $76 → $58 | Maintains | Neutral |
| 07/07/2022 | 17.13% | Jefferies | $78 → $53 | Downgrades | Hold → Underperform |
| 04/27/2022 | 67.96% | DA Davidson | $86 → $76 | Maintains | Neutral |
| 04/14/2022 | 90.06% | DA Davidson | → $86 | Initiates Coverage On | → Neutral |
| 02/10/2021 | 178.45% | Roth Capital | $107 → $126 | Maintains | Buy |
| 12/17/2020 | 136.46% | Roth Capital | → $107 | Initiates Coverage On | → Buy |
| 08/22/2019 | 43.65% | Jefferies | → $65 | Initiates Coverage On | → Hold |
| 07/03/2019 | 54.7% | Sidoti & Co. | $108 → $70 | Downgrades | Buy → Neutral |
| 04/16/2019 | — | Tigress Financial | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 2023 年 10 月 25 日 | 17.13% | DA Davidson | 62 美元 → 53 美元 | 維護 | 中立 |
| 2023 年 4 月 26 日 | 23.76% | DA Davidson | 52.5 → 56 美元 | 維護 | 中立 |
| 02/13/2023 | 16.02% | DA Davidson | 49 美元 → 52.5 美元 | 維護 | 中立 |
| 10/27/2022 | 8.29% | DA Davidson | 57 美元 → 49 美元 | 維護 | 中立 |
| 07/28/2022 | 25.97% | DA Davidson | 58 美元 → 57 美元 | 維護 | 中立 |
| 2022 年 12 月 7 日 | 28.18% | DA Davidson | 76 美元 → 58 美元 | 維護 | 中立 |
| 07/07/2022 | 17.13% | 傑富瑞集團 | 78 美元 → 53 美元 | 降級 | 持有 → 表現不佳 |
| 04/27/2022 | 67.96% | DA Davidson | 86 美元 → 76 美元 | 維護 | 中立 |
| 2022 年 4 月 14 日 | 90.06% | DA Davidson | → 86 美元 | 啓動覆蓋範圍開啓 | → 中立 |
| 2021 年 10 月 2 日 | 178.45% | 羅斯資本 | 107 美元 → 126 美元 | 維護 | 買 |
| 2020 年 12 月 17 日 | 136.46% | 羅斯資本 | → 107 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 08/22/2019 | 43.65% | 傑富瑞集團 | → 65 美元 | 啓動覆蓋範圍開啓 | → 按住 |
| 07/03/2019 | 54.7% | Sidoti & Co. | 108 美元 → 70 美元 | 降級 | 買入 → 中性 |
| 04/16/2019 | — | 泰格雷斯金融 | 啓動覆蓋範圍開啓 | → 購買 |
What is the target price for Usana Health Sciences (USNA)?
Usana Health Sciences（USNA）的目標價格是多少？
The latest price target for Usana Health Sciences (NYSE: USNA) was reported by DA Davidson on October 25, 2023. The analyst firm set a price target for $53.00 expecting USNA to rise to within 12 months (a possible 17.13% upside). 4 analyst firms have reported ratings in the last year.
DA Davidson於2023年10月25日公佈了Usana Health Sciences（紐約證券交易所代碼：USNA）的最新目標股價。該分析公司將目標股價定爲53.00美元，預計USNA將在12個月內上漲至17.13％（可能上漲17.13％）。去年有4家分析公司公佈了評級。
What is the most recent analyst rating for Usana Health Sciences (USNA)?
Usana Health Sciences（USNA）的最新分析師評級是多少？
The latest analyst rating for Usana Health Sciences (NYSE: USNA) was provided by DA Davidson, and Usana Health Sciences maintained their neutral rating.
Usana Health Sciences（紐約證券交易所代碼：USNA）的最新分析師評級由DA Davidson提供，Usana Health Sciences維持中性評級。
When is the next analyst rating going to be posted or updated for Usana Health Sciences (USNA)?
Usana Health Sciences（USNA）的下一份分析師評級何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Usana Health Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Usana Health Sciences was filed on October 25, 2023 so you should expect the next rating to be made available sometime around October 25, 2024.
分析師在進行了廣泛的研究後得出了股票評級，包括閱讀公開財務報表、與Usana Health Sciences的高管和客戶交談以及聽取業績電話會議。大多數分析師每三個月進行一次評級，因此每家公司每年應獲得4個評級。Usana Health Sciences的最後一次評級是在2023年10月25日提交的，因此你應該預計下一個評級將在2024年10月25日左右公佈。
Is the Analyst Rating Usana Health Sciences (USNA) correct?
分析師對Usana Health Sciences（USNA）的評級正確嗎？
While ratings are subjective and will change, the latest Usana Health Sciences (USNA) rating was a maintained with a price target of $62.00 to $53.00. The current price Usana Health Sciences (USNA) is trading at is $45.25, which is out of the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的Usana Health Sciences（USNA）評級保持不變，目標股價爲62.00美元至53.00美元。Usana Health Sciences（USNA）目前的交易價格爲45.25美元，超出了分析師的預測區間。
譯文內容由第三人軟體翻譯。
